When healthcare meets any other profession, amazing things happen; this is how two engineers created a completely novel anti-cancer treatment.
In this episode, CEO Lana Volokh, and CTO Alex Tendler, co-founders of ExProTher, talk about how their company is developing first-in-class cancer treatments. This oncology therapeutic delivers p53 protein into tumor cells using extracellular vesicle-based technology. They tell the story of how two engineers embarked on an entrepreneurial journey in the healthcare space and how they have overcome every barrier they have faced.
Tune in to learn more about ExProTher’s new proposal for cancer treatment!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
Outcomes Rocket